Market Closed -
Nyse
04:00:02 2025-02-14 pm EST
5-day change
1st Jan Change
126.21 USD
-0.45%
-0.91%
+6.71%
Health-care Sector Faces Mixed Prospects in 2025, Morgan Stanley Says
December 17, 2024 at 01:46 pm EST
Jana Partners Cuts Share Stake In FIS, Wolfspeed; Dissolves Share Stake In Fortrea Holdings
Feb. 14
RE
Keeping up with Donald Trump
Feb. 05
Analysts recommendations: Diageo, Tesco, Vodafone, Alphabet, Flex...
Feb. 05
Cencora raises 2025 profit forecast on specialty drug demand
Feb. 05
RE
Analyst recommendations: Alphabet, Flex, Mattel, Snap, Palantir...
Feb. 05
Jefferies Upgrades Cardinal Health to Buy From Hold, Adjusts Price Target to $150 From $140
Feb. 05
MT
Wells Fargo Adjusts Price Target on Cardinal Health to $136 From $135, Maintains Equalweight Rating
Feb. 04
MT
JPMorgan Adjusts Price Target on Cardinal Health to $145 From $142, Maintains Neutral Rating
Feb. 04
MT
Baird Adjusts Price Target on Cardinal Health to $154 From $149
Jan. 31
MT
Citigroup Adjusts Price Target on Cardinal Health to $130 From $129
Jan. 31
MT
Mizuho Adjusts Price Target on Cardinal Health to $142 From $139
Jan. 31
MT
Morgan Stanley Adjusts Price Target on Cardinal Health to $142 From $136
Jan. 31
MT
TD Cowen Adjusts Price Target on Cardinal Health to $150 From $144
Jan. 31
MT
Deutsche Bank Raises Cardinal Health Price Target to $131 From $124, Maintains Hold Rating
Jan. 31
MT
Tranche Update on Cardinal Health, Inc.'s Equity Buyback Plan announced on June 8, 2023.
Jan. 30
CI
Cardinal Health, Inc., Q2 2025 Earnings Call, Jan 30, 2025
Jan. 30
Cardinal Health's Fiscal Q2 Adjusted Earnings Rise, Revenue Falls; Raises Fiscal 2025 Adjusted EPS Guidance
Jan. 30
MT
Stocks Rise Pre-Bell as Investors Digest Key Tech Earnings; Asia, Europe Strong
Jan. 30
MT
Cardinal Health, Inc. Provides Earnings Guidance for the Year 2025
Jan. 30
CI
Earnings Flash (CAH) Cardinal Health Reports Q2 Revenue $55.26B, vs. FactSet Est of $55.02B
Jan. 30
MT
Earnings Flash (CAH) Cardinal Health Reports Q2 Adjusted EPS $1.93, vs. FactSet Est of $1.77
Jan. 30
MT
Cardinal Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2024
Jan. 30
CI
Cardinal Health, Inc. completed the acquisition of 73% stake in The GI Alliance Management, LLC from GIA physician owners and funds managed by affiliates of Apollo Global Management, Inc..
Jan. 29
CI
Cardinal Health, Inc. completed the acquisition of 73% stake in The GI Alliance Management, LLC from GIA physician owners and funds managed by affiliates of Apollo Global Management, Inc..
Jan. 29
CI
Wells Fargo Adjusts Price Target on Cardinal Health to $135 From $127, Keeps Equalweight Rating
Jan. 29
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
CAH: Dynamic Chart
Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows:
- distribution of pharmaceutical products (92.6%);
- distribution of medical, surgical and laboratory products 5.5%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.) ;
- other (1.9%).
The United States accounts for 99.3% of net sales.
More about the company
Last Close Price
126.21 USD
Average target price
140.67 USD
Spread / Average Target
+11.46%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1